Part Two: Treatment of Type IV Thoracoabdominal Aneurysms – Fenestrated Stent-graft Repair is Now the Best Option  by Haulon, S. & Greenberg, R.K.
4 S. Haulon, R.K. Greenberg15 Gilling-Smith GL, Wolfe JH. Transabdominal repair of type IV
thoraco-abdominal aortic aneurysms. Eur J Vasc Endovasc Surg
1995;9(1):112e3.
16 Richards JMJ, Nimmo AF, Moores CR, Hansen JA, Murie JA,
Chalmers RTA. Contemporary results for open repair of supra-
renal and type IV thoracoabdominal aortic aneurysms. Br J Surg
2009;97:45e9.
17 Button MCJ, Gibbs RGJ, Jenkins MP, Bicknell CD, Cheshire NJW,
Wolfe JHN. Type IV thoraco-abdominal aneurysms. Open repair
still has a place. Abstract The Vascular Society of Great Britain
and Ireland Yearbook 2009.
18 Fischbein MP, Miller DC. Long-term durability of open thoracic
and thoracoabdominal aneurysm repair. Semin Vasc Surg 2009;
22:74e80.
19 Roselli EE, Greenberg RK, Pfaff K, Francis C, Svensson LG,
Lytle BW. Endovascular treatment of thoracoabdominal
aortic aneurysms. J Thorac Cardiovasc Surg 2007;133(6):
1474e82.
ª 2011 European Society for Vascular Surgery. Published by
Elsevier Ltd. All rights reserved.
doi: 10.1016/j.ejvs.2011.04.003
Part Two: Treatment of Type IV
Thoracoabdominal Aneurysms e
Fenestrated Stent-graft Repair is
Now the Best OptionS. Haulon a,*, R.K. Greenberg baVascular Surgery, Hoˆpital Cardiologique, CHRU de Lille,
Inserm U1008, Universite´ Lille 2, 59037 Lille Cedex, France
bCleveland Clinic Foundation, Cleveland, OH, USAIntroduction
The treatment of aneurysmal disease of the aorta has seen
profound changes in the past two decades since Parodi
et al.1 performed the first endovascular aneurysm repair. In
this period devices have evolved from simple covered
tubular stents to highly complex, custom-designed devices
incorporating branches and fenestrations which allow
treatment of complex aneurysms of the abdominal and
thoracic aorta. The utility of fenestrated devices for the
treatment of juxtarenal aneurysms is now well established
with several large series confirming satisfactory interme-
diate-term outcomes.2e4 When aneurysms involve the renal
and visceral vessels, the risks of open surgery increase, and
therefore, the potential benefit of an endovascular option
increases as well. The treatment of such aneurysms with
fenestrated devices began in 2002, and has become* Corresponding author. Tel.: þ33 320 445 005.
E-mail address: stephan.haulon@chru-lille.fr (S. Haulon).increasingly more popular as the implantation technique
and device design has evolved. Publications addressing the
outcome of endovascular repair of thoracoabdominal
aneurysms (TAAA) have been quite favourable compared
with the results published for open surgery.5e10 The endo-
vascular procedure has been relegated to larger volume
centres of excellence, much like most open TAAA repair.
However, much of the published literature on endovascular
treatment of TAAAs has reported outcomes for the
conglomerate group of all types of TAAA, without specifi-
cally focussing upon any given subtype of TAAA. This has
resulted in considerable heterogeneity with respect to
reported outcomes and conclusions. This report focuses on
the outcomes and assessment of the results when the
analysis is limited to type IV TAAA.11Methods
We did a retrospective review of two prospective databases
including all patients undergoing endovascular repair of
abdominal aortic, thoracoabdominal and thoracic aneu-
rysms at the Centre Hospitalier Regional Universitaire de
Lille, Lille, France and the Cleveland Clinic, Ohio, United
States. From this database we selected the patients who
had repair of type IV TAAA using fenestrated or branched
endovascular devices. All patients treated were considered
high-risk for open repair of their aneurysm as described in
previous publication.5 In an effort to define the extent of
the design and plan the intended repair, anatomic images
were reconstructed on a 3D imaging workstation (Aquarius
WS, Terarecon Inc, Mateo, California, USA) and centreline
of flow reconstructions were used to design a customised
endoprosthesis. The design process and implantation
technique have been described in detail previously and are
beyond the scope of this article.10,14 For the purposes of
this article we defined a type IV TAAA as being any aneu-
rysm that required a branch (side-arm or reinforced
fenestration) for the superior mesenteric artery (SMA) and
at least one of the renal arteries, with a proximal sealing
zone above the visceral segment, akin to type IV TAAA as
defined by the Crawford classification.15 Follow-up clinical
assessment, laboratory testing (including eGFR evaluation),
CTA, duplex ultrasonography, and plain chest and abdom-
inal radiographs were performed at prior to discharge or
within 1 month of follow-up, then annually thereafter.
Additional follow-up studies were obtained at 6 and 18
months in selected patients.
Statistics: Means are expressed with the SD.
KaplaneMeier life-table analysis techniques were used to
estimate survival during follow-up.Results
Between January 2004 and March 2010 231 patients with
type IV TAAA were treated with an endoprosthesis. Patient
characteristics are shown in Table 1. All devices were
successfully deployed as planned. There were no acute or
late conversions to open surgical repair.
Table 1 Patient characteristics.
Patient Characteristics N Z 231
Age, mean  SD 67.9  9
Male gender, % 68
Smoking, % 58
Diabetes mellitus, % 12
Cardiac
History of CAD, % 47
EF, mean  SD* 54.2  11.2
EF <0.30, %* 5
Pulmonary
History of COPD, % 31
FEV1, mean  SD* 1.9  0.7
FEV1 <1 L, %* 17
FEF 25e75%, mean  SD* 1.1  0.8
FEF 25e75% <30% of expected, %* 42
History of cancer, % 15
BMI, mean  SD 26.8  5.1
Renal
GFR, mean  SD 69.6  28
<40, % 15
<60, % 34
Aortic diameter, mm, mean  SD 61  1.6
History of surgery for proximal aorta, % 14
History of surgery for distal aorta, % 28
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There were no intra-operative deaths. 30-day mortality
was 2.6%. Twenty four-month survival was estimated at
83%. There were no aneurysm ruptures following endo-
vascular repair. Spinal cord ischaemia developed in 2 (1%)
patients.
Branch patency
Target vessel patency was 97.8% at a mean follow-up of 15
months.16 In this analysis, there were 9 renal branch
occlusions (1.9%) that occurred at a mean of 3 months after
implantation. There were no new occlusions noted after
the one-year CT scan. Haemodialysis was required for 2 of
the 9 patients with renal occlusions. There were 3 SMA
occlusions (1.3%), one of which had a fatal result. The other
two presented with symptoms akin to chronic mesenteric
ischaemia and were successfully opened with endovascular
techniques. An asymptomatic celiac trunk occlusion was
depicted in 3 patients. These results are summarised in
Table 2.Table 2 Main outcomes.
30-day mortality 2.6%
2-year mortality 18%
Spinal cord ischaemia 1%
Permanent dialysis 1%
Target vessel patency 97.8% at 15 monthsAneurysm growth
Aneurysm growth (>5 mm) was depicted in 3 patients
during follow-up. A secondary endoleak was depicted and
treated in these 3 patients (2 type 2 and 1 type 3 endoleak).
Freedom from secondary intervention
Freedom from secondary intervention was estimated at
93% and 73% at 30 days and 24 months respectively. A
total of 44 secondary procedures were performed during
follow-up, including 12 renal artery stenting and 8 type
2 endoleak embolisation. Freedom from endoleak was
estimated at 84% and 75% at 30 days and 24 months
respectively.
Discussion
Open surgery for TAAA
Traditionally high morbidity and mortality figures associ-
ated with open repair of thoracoabdominal aneurysms12,13
and the rapid progress in endovascular technologies have
driven the evolution of endovascular techniques to treat
this particular pathology. Improvements in adjunctive
measures at open surgery have included the introduction of
distal aortic perfusion and cerebrospinal fluid drainage,
along with moderate passive hypothermia, active visceral
cooling with blood or crystalloid solution, and aggressive
intercostal artery reattachment. The introduction of these
measures has helped one reference centre to reduce their
incidence of immediate neurological deficit from 6.8% to
2.4%.17 However, these figures pertain to the treatment of
all types of TAAA without providing details of the rates of
neurological deficit for each of the subtypes of TAAA and
also describe only immediate neurological deficits. When
such results are considered, the reported overall 30-day
mortality rate of 14% appears to be quite high. Another
large series of 2286 open TAAA repair18 reported an overall
30-day mortality rate of 5%, a paraplegia/paraparesis rate
of 3.8% and a renal failure rate of 5.6%. However, when
results are limited to type IV TAAA, the risks decrease to
3%, 1.4% and 5.4% respectively in the group of 427 type IV
TAAAs. Additional complications included pulmonary issues
occurred in 734 patients (32.1%), cardiac events in 181
patients (7.9%), renal failure requiring haemodialysis in 129
(5.6%), and stroke in 40 (1.7%) in this series. A more recent
series from the United Kingdom details experience of 53
open repairs of type IV TAAA (nZ 44) or suprarenal (nZ 9)
aneurysms at a TAAA reference centre for all of Scotland.19
In this series, which is probably the most comparable to our
own, the overall 30-day mortality was 6%, cardiac compli-
cations occurred in 19%, respiratory complications in 38%
and paraplegia in 2% in addition to 6% of patients requiring
haemodialysis postoperatively (Fig. 1).
Reports from centres of excellence are critical for
evaluating the technology in question, however, the ability
to disseminate the technique in a safe and efficacious
manner is the subject of larger databases and necessary to
get a more accurate picture of the “real world”
Figure 1 Graft plan (a) of an endograft with 4 fenestrations used to treat a patient with a type IV thoracoabdominal aneurysm
situated above a previous aortic tube graft repair. Anterior (b) and lateral (c) 3D VR images of the post-operative CT scan showing
the endograft in good position with all branches patent.
6 S. Haulon, R.K. Greenbergexperience. With respect to TAAA repair, a review of the
Nationwide Inpatient Sample database (a discharge data-
base representing 20% of United States hospitals) showed
that peri-operative mortality after elective TAA repair was
22.3%, with a greater mortality risk in hospitals with lower
procedure volumes.20 A more recent California state-wide
study of more than 1000 TAAA repairs published a 19% rate
of overall perioperative mortality21 and noted a one-year
mortality rate of 31%.
Hybrid repair of TAAA
Reports from various centres describing the hybrid approach
to treatment for TAAA have produced disparate results. This
technique which involves visceral aortic debranching fol-
lowed by staged or immediate endovascular aortic relining is
generally credited to the St. Mary’s Hospital group from
London who published a series of 29 patients in 2006.22 This
initial report achieved a 30-day mortality rate of 13% with no
associatedparaplegia. This series alongwith number of other
small volume studies were reviewed by Donas et al. in 2007
who found an overall operative mortality rate of 10.7% and
a paraplegia rate of 0% in 58 patients from 13 published
reports.23 Unfortunately the initial enthusiasm for thisapproach has been somewhat tempered by more recent
reports. Chiesa published a series of 31 hybrid procedures at
his unit in Milan and reported perioperative mortality and
paraparesis/paraplegia rates of 19.4% and 9.6% respec-
tively.24 Within this paper a review of published series of
greater than ten patients yielded six studies describing 107
patients. The calculated perioperative mortality rate was
15.6% with paraparesis/paraplegia in 7.2%. Renal failure was
noted in 9.9% in this review. Interestingly the largest pub-
lished series to date is a multicentre series of 107 patients
involving the original St. Mary’s group and units at Heidelberg
and Munich in Germany.25 The operative mortality there was
14.95% and interestingly the incidence of spinal cord
ischaemia was 12.1% with permanent paraplegia in 8.4%
which is in contrast to the 0% reported in the original St.
Mary’s publication.22
Unfortunately very little data specific to this approach
for type IV TAAAs is published, with most of the afore-
mentioned series describing experiences predominantly
with types I, II and III TAAA. The general attitude appears to
limit hybrid repairs to more extensive aneurysmal disease,
while when the disease remains inferior to the diaphragm
either a pure open surgical or pure endovascular approach
is most commonly performed.
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At least 5 series of wholly endovascular repair of TAAA
consisting of more than 10 patients have been published to
date, providing data on 410 patients altogether.5e8,10 The
30-day mortality has ranged from 5.5% to 12% and spinal
cord ischaemia rates from 2.7% to 16.7%. Dialysis rates have
been between 1.4% and 9.1% with the lower rates being
reported in the larger series. In the largest of these series
from Cleveland5 the endovascular experience was pre-
sented in tandem with the open surgery experience over
the same 67 month period. Patients undergoing endovas-
cular repair were statistically older and had more comor-
bidities. Outcomes between the open repair group and the
endovascular repair group were broadly similar with no
significant difference in 30-day or one-year mortality data,
implying that results equivalent to, or even superior than,
open surgery in healthy patients can be obtained in an
older sicker patient population with an endovascular
approach. The authors in this series also compared the 30-
day mortality and spinal cord ischaemia rates between
open (n Z 64) and endovascular surgery (n Z 69) specifi-
cally for type IV TAAA repair and found no significant
difference between the groups. Interestingly however,
one-year mortality in the open group at 22%, was almost
twice that of the endovascular group at 12% even when the
endovascular patients were a considerable less robust
group.
The data presented in the results section are the largest
series published to date specifically concerning the endo-
vascular treatment of type IV TAAA. The patients in this
series were considered high-risk for open surgical repair
and intuitively one would expect that their outcomes would
be worse than those attained at open repair in fitter
patients. This however has not been the observed experi-
ence and the outcomes achieved in this group of patients
appear excellent when compared to those achieved at open
surgery. Critics of the endovascular approach to these
aneurysms raise concerns about the long-term integrity of
the endoprosthesis and the visceral branches but experi-
ence to date with branched and fenestrated endografts for
the treatment of juxtarenal aneurysms has shown the
devices to be durable in the medium and long term.2e4
Indeed one of these series from the Netherlands of 100
patients undergoing fenestrated endovascular repair of
juxtarenal aneurysms has demonstrated a branch patency
rate of 93.3% with up to five year follow-up suggesting good
durability of the devices.4 All branch occlusions in this
series occurred in the first two years of follow-up. No
aneurysm related death occurred at five year follow-up. A
further study from the Cleveland Clinic16 with a mean
follow-up of 26 months (range 9 months-6 years), followed
the fate of 518 renal arteries stented during the course of
endovascular repair of juxtarenal or thoraco-abdominal
aneurysms with either covered or uncovered stents. A total
of 18 (3.5%) arteries occluded during follow-up with a rate
of only 2.2% observed in cases where covered stents were
deployed and a rate of 4.5% in cases where uncovered
stents were used. Most (11 of the 18) renal stent occlusions
occurred prior to the 1-month CT scan. The remaining
seven occlusions occurred between the 1-month and 6-month studies. There were no late renal stent occlusions.
36 renal stent stenoses were detected during follow-up,
but only 7 required secondary procedures. Again the
covered stents performed better with a 2.5% rate of
stenosis, versus a 10% rate of stenosis as observed with
uncovered stents.
As mentioned in the introduction, endovascular
approaches to repair of juxtarenal aneurysms and type IV
TAAAs are technically comparable apart from the minor
difference in the degree of aortic coverage required and also
the routine necessity for a branch or fenestration for the SMA
and/or the celiac trunk. If the extra degree of aortic
coverage involved were to be a genuine problem, then one
would expect to see a significant incidence of spinal cord
ischaemia in patients undergoing endovascular repair, but
this does not appear to be the case with a small rate of spinal
cord ischaemianoted inour series (1%). In addition, excellent
target vessel patency rates, uniformly in excess of 90%, have
been reported in all the series describing endovascular repair
of TAAA todateand theaforementionedDutchandCleveland
Clinic studies4,16 suggest that if problems with stent patency
are to occur, then they will occur early rather than late.
Indeed it is likely that the presence of additional or improved
stents for the visceral vessels may in fact offer protection
against device migration.
In spite of the high quality long-term multicenter
endovascular data, the endovascular data appears to be
more robust than any of the surgical reports. There has
never been a multicenter study on the open surgical
treatment of thoracoabdominal aneurysms. There is no
consensus on how and when open surgical patients should
be reimaged, in spite of a considerable risk of failure
following open surgery.26 In this light, it seems a little
short-sighted to criticize the lack of long-term data or
hypothesize about failing device integrity, when no well
studied alternative exists. In fact, the data in this series
support the application of these technologies to treat
type IV TAAA over an open surgical approach, when
employed by skilled clinicians operating in centres of
excellence.
The debate regarding the best option for repair of TAAA
will no doubt continue, but when looking at this topic it is
important to differentiate between the different types of
TAAA to inform policy. Our series demonstrates the safety
of the fenestrated endograft approach to type IV TAAA
repair. Outcomes from various studies have shown at least
equivalence of the endovascular approach in terms of
spinal cord ischaemia and 30-day mortality. One-year
survival may even be improved. The incidence of cardiac,
respiratory and renal complications appears to be signifi-
cantly greater in patients undergoing open surgery and,
given the excellent results of fenestrated endografting for
other analogous pathologies it is now, we believe, the
preferred option for repair of type IV TAAA.Conflict of Interest/Funding
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Part Three: Open Repair is the Best
Option for Type IV Thoracoabdominal
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Introduction
Thoracoabdominal aortic aneurysms (TAAA) have long
proven one of the most challenging clinical scenarios to
confront vascular surgeons. Open repair has traditionally
required extensive aortic dissection, often involving theE-mail address: Tom.Forbes@lhsc.on.ca.
